Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (отвара нови прозор)

Barillari G, Pasca S, Barillari A, De Angelis V.

Извор‎: Blood Transfus 2012;10(1):87-94.

Индекс‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (отвара нови прозор)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (отвара нови прозор)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Извор‎: Chest 2012;141(2 Suppl):e326S-50S.

Индекс‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (отвара нови прозор)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (отвара нови прозор)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Извор‎: Lancet 2015;385(9982):2077-87.

Индекс‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (отвара нови прозор)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (отвара нови прозор)

Hanke AA, Joch C, Görlinger K.

Извор‎: Br J Anaesth 2013;110(5):764-72.

Индекс‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (отвара нови прозор)

Emergency reversal of warfarin anticoagulation. (отвара нови прозор)

Lin Y, Callum J.

Извор‎: CMAJ 2010;182(18):2004.

Индекс‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (отвара нови прозор)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (отвара нови прозор)

Mo Y, Yam FK.

Извор‎: Pharmacotherapy 2015;35(2):198-207.

Индекс‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (отвара нови прозор)

Idarucizumab for dabigatran reversal - full cohort analysis. (отвара нови прозор)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Извор‎: N Engl J Med 2017;377(5):431-41.

Индекс‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (отвара нови прозор)

Oral anticoagulation in surgical procedures: risks and recommendations. (отвара нови прозор)

Torn M, Rosendaal FR.

Извор‎: Br J Haematol 2003;123(4):676-82.

Индекс‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (отвара нови прозор)